Loading stock data...
Arbutus Biopharma Corporation (ABUS) Stock Price, Chart & Analysis
Arbutus Biopharma CorporationABUS
Market Closed$3.71
+$0.04+1.09%
ABUS Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for ABUS to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Arbutus Biopharma Corporation (ABUS)
Loading chart data...
Is Arbutus Biopharma Corporation (ABUS) Stock a Buy in 2025?
NO
HOLD
Score: 62/100
No, ABUS stock may not be the best buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether ABUS stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 41.6% upside potential
- Small-cap with higher growth potential and volatility
Risk Factors
- High debt-to-equity ratio of 6.03
- Healthcare sector cyclicality
- Small-cap liquidity and volatility risks
Analyst Consensus
Buy Ratings:1
Hold Ratings:3
Sell Ratings:0
Avg. Price Target:$5.25
Upside Potential:41.6%
Investment Summary
ABUS presents a mixed investment profile for 2025. The company shows strong growth drivers including healthcare sector momentum, though analyst price targets suggest 41.6% upside potential.
Analyst sentiment is generally positive with 1 buy ratings vs 0 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 6.03, and consider their own risk tolerance and investment timeline.
Final Recommendation
HOLD
Recommendation Score
Overall Score:62/100
Hold
2030 Price Prediction
Predicted Price:$11.32
Potential Return:+205.1%
Key Factors
- Significantly declining revenue
- Some analyst support
- Significant upside potential
- Exceptional long-term growth potential to 2030
- Extremely high debt levels
- Debt-to-Market-Cap Ratio: 0.7% (Very Low)
Investment Decision
Based on our comprehensive analysis of ABUS's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a HOLD. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
abus Stock Price Prediction 2030
Predicted 2030 Price
$11.32
+205.1%from current price
Based on revenue growth analysis and market trends, abus stock is projected to reach $11.32 by 2030, representing a 205.1% increase from the current price of $3.71.
Current Price
$3.71
Revenue Growth
522.2%
Analyst Target
$5.25
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in abus Stock?
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
4. Investment Decision
Make buy/hold/sell decision with price targets
Company Profile
Arbutus Biopharma Corporation
Healthcare
Biotechnology
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline compr...
Employees
44
Market Cap
$711.20M